Patents by Inventor Pascal Collette

Pascal Collette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenol derivatives and the pharmaceutical or cosmetic use thereof
    Patent number: 10202346
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: February 12, 2019
    Assignee: Galderma Research & Development
    Inventors: Cedric Poinsard, Pascal Collette, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore
  • NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20170037015
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • Phenol derivatives and pharmaceutical or cosmetic use thereof
    Patent number: 9505720
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: November 29, 2016
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Pascal Collette, Jean-Michel Linget, Sandrine Rethore, Pascale Mauvais
  • NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20160115132
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: May 8, 2015
    Publication date: April 28, 2016
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20160068488
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: July 27, 2015
    Publication date: March 10, 2016
    Inventors: Cedric POINSARD, Pascal COLLETTE, Pascale MAUVAIS, Jean-Michel LINGET, Sandrine RETHORE
  • Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
    Patent number: 8877968
    Abstract: Melanocortin receptor modulators, processes for preparing them and use thereof in human medicine and cosmetics are described. Melanocortin receptor modulators corresponding to formula (I): compositions containing them, processes for their preparation and their use in pharmaceutical or cosmetic compositions are also described.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: November 4, 2014
    Assignee: Galderma Research & Development
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Isabelle Pelisson, Pascal Collette, Samuel Tabet, Guillaume Lafitte
  • MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THERE IN HUMAN MEDICINE AND COSMETICS
    Publication number: 20110275657
    Abstract: Melanocortin receptor modulators, processes for preparing them and use thereof in human medicine and cosmetics are described. Melanocortin receptor modulators corresponding to formula (I): compositions containing them, processes for their preparation and their use in pharmaceutical or cosmetic compositions are also described.
    Type: Application
    Filed: November 4, 2009
    Publication date: November 10, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Isabelle Pelisson, Pascal Collette, Samuel Tabet, Guillaume Lafitte
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7807669
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: October 5, 2010
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Modulators of lanosterol synthetase for treating acne or hyperseborrhea
    Publication number: 20100021893
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of lanosterol synthetase (LSS), and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: January 28, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Mohamed El-Alfy, Van Luu-The, Ezequiel L. Calvo, Jerome Aubert, Pascal Collette, Johannes Voegel
  • Modulators of ELOVL5 for treating acne or hyperseborrhea
    Publication number: 20090298074
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of ELOVL5 and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: December 3, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Mohamed El-Alfy, Van Luu-The, Ezequiel L. Calvo, Pascal Collette, Sophie Deret, Michel Rivier
  • Modulators of the transporter ABCD3 for treating acne or hyperseborrhea
    Publication number: 20090258356
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of the peroxisome membrane transporter 1 comprising a type 3 ATP-binding site of the sub-family D (ABCD3), and the use of modulators of the expression or activity of this transporter for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: October 15, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Mohamed El-Alfy, Ezequiel L. Calvo, Isabelle Carlavan, Pascal Collette, Sophie Deret, Michel Rivier
  • Modulators of scarb-1 for treating acne or hyperseborrhea
    Publication number: 20090246776
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of the SCARB-1 receptor, and the use of modulators of the expression or activity of this receptor for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: October 1, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Isabelle Carlavan, Pascal Collette, Ezequiel L. Calvo, Jerome Aubert, Johannes Voegel
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7582663
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: September 17, 2007
    Date of Patent: September 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Pharmaceutical/cosmetic compositions comprising a novel RARbeta receptor-activating ligand
    Patent number: 7517907
    Abstract: Novel ligand compounds having the structural formula (I): and the salts and optical/geometrical isomers thereof are suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: April 24, 2006
    Date of Patent: April 14, 2009
    Assignee: Galderma Research & Development
    Inventor: Pascal Collette
  • NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE PPARY TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
    Publication number: 20090062340
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: November 6, 2008
    Publication date: March 5, 2009
    Applicant: Galderma Research & Development
    Inventors: LAURENCE CLARY, CLAIRE BOUIX-PETER, MICHEL RIVIER, PASCAL COLLETTE, ANDRE JOMARD
  • Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
    Patent number: 7468457
    Abstract: Novel biaryl compounds having the structural formula (I): are useful in a variety of pharmaceutical applications, whether human or veterinary, and also in cosmetics.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: December 23, 2008
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Pascal Collette
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7452878
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: November 18, 2008
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20080070957
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: September 17, 2007
    Publication date: March 20, 2008
    Applicant: Galderma Research & Development, S.N.C.
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
    Patent number: 7326803
    Abstract: Novel bicyclic compounds having the structural formula (I): are useful in a variety of pharmaceutical applications, whether human or veterinary, and also in cosmetics.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: February 5, 2008
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Pascal Collette
  • Polycyclic compounds which modulate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7307078
    Abstract: Novel polycyclic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: December 11, 2007
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Pascal Collette, Michel Rivier, Andre Jomard